Niromed’s Post

👉 Starting from July 1, 2024, the government of Kazakhstan has established mandatory requirements for the individual digital marking of pharmaceuticals. Thanks to digital technologies for tracking and ensuring market transparency, the country aims to strengthen its fight against the shadow pharmaceutical market and the production of counterfeit products. 📌 The implementation of this new legislative initiative enables control over the production and importation of medications, as well as their logistics, distribution, and consumption. "Arterium" Corporation was one of the first companies to promptly update its registration dossiers and successfully implemented the individual digital marking project among non-resident companies in of Kazakhstan and Ukrainian pharmaceutical companies. Now, each package of "Arterium" products shipped to Kazakhstan is marked with an individual digital code that complies with regulatory requirements. 🤝 The project was realized in a short time thanks to the professional team and the available material and technical resources. Kazakhstan is the third country to which products under the "Arterium" trademark are being shipped with individual digital labeling. It is worth noting that Kazakhstan is one of the largest external markets for "Arterium" products. 📅 We adhere to all legislative and regulatory requirements in the markets where we operate and promptly respond to changes to ensure the regular supply of "Arterium" brand medications to patients. #Arterium #Kazakhstan #digital #individualcode

U.S. Importation of Drugs: Navigating the Impact on Canadian Drug Supply On January 5, 2024, the U.S. Food and Drug Administration (FDA) signed off on Florida’s request to import prescription drugs from Canada under the Section 804 State Importation Program (SIP). This approval has sparked significant discussions and raised concerns about the potential impact on the Canadian drug supply. While this decision aims to address the rising costs of medications in the United States, it has also prompted a closer examination of the implications for Canada's pharmaceutical landscape. In the meantime, pharmaceutical companies have measures at their disposal to help curb export from Canada, including, for example, modifying the terms and conditions of sale to wholesalers. https://ow.ly/opK850QuS2X Sometimes getting to “DONE” is as easy as coffee and conversation … how about we chat. #groupbenefits #employeebenefits #consulting #leadership #communication #cepa #culture #compensation #wellness #employeeengagement #cgib #productivity #roi Humans SERVING Humans

U.S. Importation of Drugs: Navigating the Impact on Canadian Drug Supply On January 5, 2024, the U.S. Food and Drug Administration (FDA) signed off on Florida’s request to import prescription drugs from Canada under the Section 804 State Importation Program (SIP). This approval has sparked significant discussions and raised concerns about the potential impact on the Canadian drug supply. While this decision aims to address the rising costs of medications in the United States, it has also prompted a closer examination of the implications for Canada's pharmaceutical landscape. In the meantime, pharmaceutical companies have measures at their disposal to help curb export from Canada, including, for example, modifying the terms and conditions of sale to wholesalers. https://ow.ly/Ai2150QuS2T Sometimes getting to “DONE” is as easy as coffee and conversation … how about we chat. #groupbenefits #employeebenefits #consulting #leadership #communication #cepa #culture #compensation #wellness #employeeengagement #cgib #productivity #roi Humans SERVING Humans

Prof. Mojidola Adeyeye, the Director-General of the NAFDAC disclosed that NAFDAC under her leadership started the “5 plus 5” regulatory scheme which entails companies importing drugs that could be produced by the local pharmaceutical industry to get a last five-year renewal. She said that during the five-year renewal period, the importer must migrate to local manufacturing or partner with local manufacturers, adding that this was an outcome of a study. She said that over 30% of new companies in Nigeria sprung up as a result of the “5 plus 5” initiative, adding that it had encouraged many importers to build their companies. Stay tuned for more updates and photos from this exciting venture on our LinkedIn page! #nigeria #NAFDAC #qualitymedicine #export #Innovation #dailyupdate #pharmaceuticalindustry

#pharmaceuticals >> Pharmaceutical Sector of Ukraine: significant contribution to the budget and economy of the country 📈 In 2023, Ukraine’s pharmaceutical sector paid more than UAH 5 billion in taxes to the state budget, which confirms its key role in supporting the national economy. 💊 Pharmaceutical retail continues to operate steadily despite economic challenges, providing the population with the necessary medicines and supporting local employees. These figures demonstrate the strategic importance of the sector for Ukraine's development. Another important news is the introduction of the National Drug Verification System using 2D coding for pharmaceuticals. This system is aimed at protecting medicines from counterfeiting. The policy requires manufacturers to include safety measures on the packaging of medicinal products to enable traceability and guarantee their quality. Participation will be voluntary starting from January 1, 2026, and mandatory from January 1, 2028. 🔍 The introduction of this system is another step towards increasing the transparency and safety of the Ukrainian pharmaceutical market. Links: https://lnkd.in/dTHBr-Mi https://lnkd.in/dVPRuTSJ https://lnkd.in/d6efj8-k #pharmaceuticals #pharma #Ukraine #EasternEurope #pharmaindustry

With growing attention on #LocalManufacturing in the #PharmaceuticalIndustry in #Africa one critical piece in ensuring reliable and consistent production is a robust #SupplyChain system. This ranges from the coordination of #API vendor selection, qualification, procurement and coordination of supplies in line with production cycles. Beyond the manufacturing piece, there's a need to ensure produce gets to the market in a timely manner to the right market with predictable cycles that ensure consistent access. The African Pharmaceutical Network (APN) through the #PharmacyAcademy has invested in #WorkforceDevelopment with an offering in Pharmaceutical Supply Chain Management that will address these nuances ensuring local pharmaceutical players have reliable competent pool of professionals to work with in the continent. Enroll: https://lnkd.in/dSG4RGRU #AfricaWeWant #AfricaRising #PharmaIndustry

Global data suggests that the Philippine pharmaceutical market will grow to reach P241.9 billion. The Philippine Economic Zone Authority (PEZA) sees an increase in investments for medical and drug manufacturing with the creation of pharmaceutical economic zones (pharma ecozones) in the Philippines. Amidst this trend, the need to find efficiencies in processes for customers is a key priority. Outsource the logistics functions to us so you can focus on this and your core. We have the solutions you need to succeed! Contact us to learn more about our services: - Air, Sea, and Land Freight Services - Door-to-door and Port-to-port Delivery - Trucking Services and Warehousing Solutions For cargo booking, message or call us now at (02) 8643 5469 / 0977 783 1263 or visit our website https://lnkd.in/gzT9TThv #logistics #logisticsplanning #freighttransport #aircargo #OntoTheNext

In 2022, the value of #pharmaceutical_exports_from_Hungary reached 6.7 billion euros, while imports stood at 4.9 billion euros. #Romania and #Germany are the leading export markets for pharmaceutical goods manufactured in #Hungary.

𝐒𝐡𝐢𝐟𝐭𝐢𝐧𝐠 𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐒𝐚𝐮𝐝𝐢 𝐀𝐫𝐚𝐛𝐢𝐚'𝐬 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 In the past, selling products through distribution rights was a common strategy for Saudi Arabian pharmaceutical companies. However, this trend is changing. 𝐏𝐨𝐥𝐢𝐜𝐲 𝐃𝐫𝐢𝐯𝐞𝐬 𝐋𝐨𝐜𝐚𝐥 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭: Government policies are pushing the industry towards innovation and drug development. This means simply obtaining distribution rights is no longer enough. 𝐅𝐨𝐜𝐮𝐬 𝐨𝐧 𝐒𝐞𝐥𝐟-𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭: The focus now lies on building internal capabilities for drug development and technical expertise. This allows Saudi companies to compete on a global scale. 𝐈𝐦𝐩𝐚𝐜𝐭 𝐨𝐧 𝐋𝐢𝐜𝐞𝐧𝐬𝐢𝐧𝐠 𝐃𝐞𝐚𝐥𝐬: This policy shift is driving a demand for exclusive licensing rights and access to broader intellectual property (IP) ownership. Additionally, regulations are being implemented to support these goals. 𝐎𝐯𝐞𝐫𝐚𝐥𝐥, 𝐒𝐚𝐮𝐝𝐢 𝐀𝐫𝐚𝐛𝐢𝐚'𝐬 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐢𝐬 𝐮𝐧𝐝𝐞𝐫𝐠𝐨𝐢𝐧𝐠 𝐚 𝐬𝐢𝐠𝐧𝐢𝐟𝐢𝐜𝐚𝐧𝐭 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧, 𝐩𝐫𝐢𝐨𝐫𝐢𝐭𝐢𝐳𝐢𝐧𝐠 𝐬𝐞𝐥𝐟-𝐬𝐮𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲 𝐚𝐧𝐝 𝐠𝐥𝐨𝐛𝐚𝐥 𝐜𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞𝐧𝐞𝐬𝐬.

🔊 🌟 New Frontiers, New Opportunities: Expepharma now available in Italian! 🇮🇹 We're excited to share an important milestone for Expepharma! Already available in English, French, German and Arabic, our platform is now enriched with a specific Italian version 🇮🇹👏, accompanied by a complete selection of Italian pharmaceutical products. This expansion demonstrates our commitment to strengthening #connectivity and #accessibility in the global #pharmaceutical market. It's a unique opportunity for all of us to explore new horizons and take advantage of the unique opportunities Expepharma offers. Plus, remember that using the platform is 100% FREE for all our users!🎁 Let's embark on this journey together and unlock the limitless possibilities that Expepharma has to offer. ➕➕ https://lnkd.in/eaWvFZZU #ExpePharma #PharmaceuticalInnovation #GlobalHealth #Italy #Pharma #FreeOpportunity #Wholesalers #ParallelTrade #MedicineShortages #Laboratories #PharmaceuticalDistributor #PharmaSourcing